1
|
Gouveia I, Geraldo AF, Godinho C, Castedo S. Feingold syndrome type 1: a rare cause of fetal microcephaly (prenatal diagnosis). BMJ Case Rep 2023; 16:e254366. [PMID: 36889805 PMCID: PMC10008251 DOI: 10.1136/bcr-2022-254366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/10/2023] Open
Abstract
We report a case of fetal microcephaly found during the second trimester ultrasound and confirmed by further ultrasound scans and fetal MRI. The array comparative genomic hybridisation analysis of the fetus and the male parent showed a 1.5 Mb deletion overlapping the Feingold syndrome region, an autosomal dominant syndrome that can cause microcephaly, facial/hand abnormalities, mild neurodevelopmental delay and others. This case illustrates the need for a detailed investigation by a multidisciplinary team to provide prenatal counselling regarding a postnatal outcome to the parents and orient their decision towards the continuation or termination of pregnancy.
Collapse
Affiliation(s)
- Inês Gouveia
- Obstetrics and Gynecology, Centro Hospitalar de Vila Nova de Gaia Espinho EPE, Vila Nova de Gaia, Portugal
| | - Ana Filipa Geraldo
- Diagnostic Neuroradiology Unit, Radiology Department, Centro Hospitalar de Vila Nova de Gaia Espinho EPE, Vila Nova de Gaia, Portugal
| | - Cristina Godinho
- Obstetrics and Gynecology, Centro Hospitalar de Vila Nova de Gaia Espinho EPE, Vila Nova de Gaia, Portugal
| | - Sérgio Castedo
- Genetics Department of Faculty of Medicine, Universidade do Porto, Porto, Portugal
- Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
| |
Collapse
|
2
|
Wagner MW, Poretti A, Benson JE, Huisman TAGM. Neuroimaging Findings in Pediatric Genetic Skeletal Disorders: A Review. J Neuroimaging 2016; 27:162-209. [PMID: 28000960 DOI: 10.1111/jon.12413] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2016] [Accepted: 11/01/2016] [Indexed: 12/15/2022] Open
Abstract
Genetic skeletal disorders (GSDs) are a heterogeneous group characterized by an intrinsic abnormality in growth and (re-)modeling of cartilage and bone. A large subgroup of GSDs has additional involvement of other structures/organs beside the skeleton, such as the central nervous system (CNS). CNS abnormalities have an important role in long-term prognosis of children with GSDs and should consequently not be missed. Sensitive and specific identification of CNS lesions while evaluating a child with a GSD requires a detailed knowledge of the possible associated CNS abnormalities. Here, we provide a pattern-recognition approach for neuroimaging findings in GSDs guided by the obvious skeletal manifestations of GSD. In particular, we summarize which CNS findings should be ruled out with each GSD. The diseases (n = 180) are classified based on the skeletal involvement (1. abnormal metaphysis or epiphysis, 2. abnormal size/number of bones, 3. abnormal shape of bones and joints, and 4. abnormal dynamic or structural changes). For each disease, skeletal involvement was defined in accordance with Online Mendelian Inheritance in Man. Morphological CNS involvement has been described based on extensive literature search. Selected examples will be shown based on prevalence of the diseases and significance of the CNS involvement. CNS involvement is common in GSDs. A wide spectrum of morphological abnormalities is associated with GSDs. Early diagnosis of CNS involvement is important in the management of children with GSDs. This pattern-recognition approach aims to assist and guide physicians in the diagnostic work-up of CNS involvement in children with GSDs and their management.
Collapse
Affiliation(s)
- Matthias W Wagner
- Section of Pediatric Neuroradiology, Division of Pediatric Radiology, Russell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD.,Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland
| | - Andrea Poretti
- Section of Pediatric Neuroradiology, Division of Pediatric Radiology, Russell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD
| | - Jane E Benson
- Section of Pediatric Neuroradiology, Division of Pediatric Radiology, Russell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD
| | - Thierry A G M Huisman
- Section of Pediatric Neuroradiology, Division of Pediatric Radiology, Russell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD
| |
Collapse
|
3
|
Fiori E, Babicola L, Andolina D, Coassin A, Pascucci T, Patella L, Han YC, Ventura A, Ventura R. Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2. Behav Genet 2015; 45:547-59. [PMID: 26026879 PMCID: PMC4561592 DOI: 10.1007/s10519-015-9724-8] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2014] [Accepted: 05/20/2015] [Indexed: 12/13/2022]
Abstract
Feingold syndrome (FS) is an autosomal dominant disorder characterized by microcephaly, short stature, digital anomalies, esophageal/duodenal atresia, facial dysmorphism, and various learning disabilities. Heterozygous deletion of the miR-17-92 cluster is responsible for a subset of FS (Feingold syndrome type 2, FS2), and the developmental abnormalities that characterize this disorder are partially recapitulated in mice that harbor a heterozygous deletion of this cluster (miR-17-92∆/+ mice). Although Feingold patients develop a wide array of learning disabilities, no scientific description of learning/cognitive disabilities, intellectual deficiency, and brain alterations have been described in humans and animal models of FS2. The aim of this study was to draw a behavioral profile, during development and in adulthood, of miR-17-92∆/+ mice, a genetic mouse model of FS2. Moreover, dopamine, norepinephrine and serotonin tissue levels in the medial prefrontal cortex (mpFC), and Hippocampus (Hip) of miR-17-92∆/+ mice were analyzed.Our data showed decreased body growth and reduced vocalization during development. Moreover, selective deficits in spatial ability, social novelty recognition and memory span were evident in adult miR-17-92∆/+ mice compared with healthy controls (WT). Finally, we found altered dopamine as well as serotonin tissue levels, in the mpFC and Hip, respectively, of miR-17-92∆/+ in comparison with WT mice, thus suggesting a possible link between cognitive deficits and altered brain neurotransmission.
Collapse
Affiliation(s)
- E. Fiori
- Dipartimento di Psicologia and Centro “Daniel Bovet”, Sapienza - Università di Roma, Rome, Italy
- Santa Lucia Foundation, European Centre for Brain Research (CERC), Via del Fosso di Fiorano, 64, 00143 Rome, Italy
| | - L. Babicola
- Santa Lucia Foundation, European Centre for Brain Research (CERC), Via del Fosso di Fiorano, 64, 00143 Rome, Italy
- Dipartimento di Scienze e Tecnologie Biomediche, Università dell’Aquila, L’Aquila, Italy
| | - D. Andolina
- Santa Lucia Foundation, European Centre for Brain Research (CERC), Via del Fosso di Fiorano, 64, 00143 Rome, Italy
- Dipartimento di Scienze e Tecnologie Biomediche, Università dell’Aquila, L’Aquila, Italy
| | - A. Coassin
- Dipartimento di Psicologia and Centro “Daniel Bovet”, Sapienza - Università di Roma, Rome, Italy
- Santa Lucia Foundation, European Centre for Brain Research (CERC), Via del Fosso di Fiorano, 64, 00143 Rome, Italy
| | - T. Pascucci
- Dipartimento di Psicologia and Centro “Daniel Bovet”, Sapienza - Università di Roma, Rome, Italy
- Santa Lucia Foundation, European Centre for Brain Research (CERC), Via del Fosso di Fiorano, 64, 00143 Rome, Italy
| | - L. Patella
- Santa Lucia Foundation, European Centre for Brain Research (CERC), Via del Fosso di Fiorano, 64, 00143 Rome, Italy
- Dipartimento di Scienze e Tecnologie Biomediche, Università dell’Aquila, L’Aquila, Italy
| | - Y.-C. Han
- Pfizer- Oncology, Pearl River, NY, USA
| | - A. Ventura
- Memorial Sloan-Kettering Cancer Center, Cancer Biology & Genetics Program, New York, NY, USA
| | - R. Ventura
- Santa Lucia Foundation, European Centre for Brain Research (CERC), Via del Fosso di Fiorano, 64, 00143 Rome, Italy
| |
Collapse
|